Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03591731
Title Nivolumab +/- Ipilimumab in Patients With Advanced, Refractory Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Tumors (NECs) (NIPINEC)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Intergroupe Francophone de Cancerologie Thoracique
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Centre Hospitalier du Pays d'Aix Aix-en-Provence France Details
CHU d'Amiens-Picardie Amiens France Details
CHU d'Angers Angers France Details
Auxerre - CH Auxerre 89011 France Details
Avignon - CH Avignon France Details
Lyon - Hôpital Edouard Herriot Lyon France Details
Paris - Curie Paris France Details
*Shaded cells indicate that there was no data available from for the field